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Abstract This paper presents homogeneous clusters of
patients, identified in the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI) data population of 317
females and 342 males, described by a total of 243 bio-
logical and clinical descriptors. Clustering was performed
with a novel methodology, which supports identification of
patient subpopulations that are homogeneous regarding
both clinical and biological descriptors. Properties of the
constructed clusters clearly demonstrate the differences
between female and male Alzheimer’s disease patient
groups. The major difference is the existence of two male
subpopulations with unexpected values of intracerebral and
whole brain volumes.
Keywords Alzheimer’s disease  Clustering 
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1 Introduction
A key issue in understanding of the Alzheimer’s disease
(AD) is the recognition of relations between clinical
characteristics of patients and their biological properties
that can be objectively measured. Some recent studies [1]
suggest the existence of different AD subtypes, and it may
be expected that the identification of relevant relations is
potentially easier for AD subtypes than for the complete
AD population. Additionally, segmentation of the AD
population may enable comparative evaluation of subpop-
ulations of AD patients, potentially leading to a better
understanding of their distinguishing properties.
An important characteristic of the proposed approach
applied in this work is that clustering is performed sepa-
rately for male and female populations, and that the gen-
erated patient clusters are homogeneous both in terms of
clinical and biological properties. The results are relevant
for identification of gender-specific properties of patients
that have problems with dementia. Also, the results clearly
support the conclusion that there are significant gender-
related differences among AD patients [2].
Development of our clustering methodology has been
motivated by the recently introduced approaches of
redescription mining [3] and multi-view learning [4]. We give
a detailed presentation of the proposed multi-layer clustering
algorithm (MLC), since we believe that this methodology can
be useful also in other medical applications. The algorithm is
implemented as a web application and is easy to use. It is
publicly available at http://rr.irb.hr/MLC/.
For the Alzheimer’s Disease NeuroimagingInitiative.
Data used in this work were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As
such, the investigators within the ADNI contributed to the design and
implementation of ADNI and/or provided data but did not participate
in analysis or writing of this report. A complete listing of ADNI
investigators can be found at http://adni.loni.usc.edu/wp-content/
uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
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Applications of data clustering are very good examples
of interactive data mining approaches [5] because evalua-
tion of the quality of obtained clusters is only possible in
the context of domain expert’s expectations [6]. Addi-
tionally, an important issue is that application of different
clustering algorithms as well as different ways of data
representation and preparation may result in substantially
different clustering results.
Unfortunately, it was not possible to include experts
participating in the ADNI into the analysis loop of our
clustering of the ADNI data. Expert evaluation of the
results solely with the help of publicly available data and
their descriptions is difficult because some data or their
aspects, especially anamnestic data and data collection
procedures, are not public due to patient privacy protection
issues. Nevertheless, we still used human-in-the-loop
approach that concentrated on the identification of sub-
populations that are large and interpretable with existing
domain knowledge. As a result—besides some clusters that
are in agreement with the existing domain knowledge—we
have surprisingly identified some additional clusters that
are hard to evaluate. These clusters are currently consid-
ered as potentially interesting hypotheses; their future
verification on independent data might lead to new scien-
tific insights and potentially useful medical knowledge.
The rest of the paper starts with a summary of the
related work in Sect. 2 and the presentation of the data
used in the analysis in Sect. 3. Section 4 describes the
novel clustering methodology, including a small illustrative
example. Section 5 presents the constructed clusters of
ADNI patients. The clusters are described in terms of sta-
tistical properties of patients included into each cluster,
together with the complete list of identification numbers of
corresponding patients. In this way, the interested reader
may access additional information about specific patients
from the ADNI database. Medical relevance of the results,
especially a possible interpretation of the unexpected
clusters is discussed in Sect. 6. The quality of best
biomarkers for the constructed clusters is analyzed in
Sect. 7. Section 8 concludes the paper.
2 Related work
The approaches suitable for the identification of relations
between clinical and biological properties of AD patients
can be grouped into three groups. In the first one, we have
statistical approaches that typically test the significance of
differences between properties of AD patients and patients
from the control group. Published results obtained with
these methods [7, 8] clearly demonstrate the existence of
relations between the values obtained by PET imaging and
the clinical diagnosis. The problem with this approach is
that the identified relations are non-specific and that the
severity of the disease is not strongly correlated with the
measured values. The major problem seems to be that the
differences in biological descriptors may be a consequence
of various physiological processes and that changes of both
clinical and biological variables may be a normal process
in the elderly population.
Other approaches are based on data mining methods.
The second group comprises supervised machine learning
techniques used for identification of potentially complex
relations between biological properties that strongly cor-
relate with the AD diagnosis [9]. This is typically a very
powerful approach but in the AD domain it is confronted
with the problem that there exist various clinical scales of
dementia but none of them can be regarded as completely
reliable for determining the AD diagnosis.
The third group comprises unsupervised clustering
approaches, which are very attractive because they do not
require explicit definition of the target class and the
availability of a control group of patients. The results often
enable novel insights into the analyzed data. A good
example is the identification of pathological subtypes of the
Alzheimer’s disease presented in one large group charac-
terized by the distribution of senile plaque restricted to a
small number of brain regions, and a smaller group with
about 15 % of patients in which the lesions were more
widely distributed [10]. A general problem of clustering is
instability of the results that significantly depend on the
used methodology and the parameters of the algorithm
selected by the user [11]. Recently, it has been demon-
strated that the quality of results can be significantly
improved when more than one layer of input data are used
[3, 4]. The distinguishing property of the multi-layer
clustering algorithm presented in this work is that—in
contrast to redescription mining [3]—our algorithm does
not construct descriptions of subpopulations and that—in
contrast to multi-view learning [4]—it does not require
statistical independence of input data layers. Additionally,
the major advantage of the multi-layer clustering algorithm
is that no explicit definition of the distance measure among
instances (patients) is necessary and that no explicit defi-
nition of the number or size of the resulting clusters is
expected from the user [12].
The first experiments with the application of the multi-
layer clustering in the AD domain have been performed on
916 patients from the ADNI database described by 10
biological and 23 clinical descriptors [13]. The results
demonstrated the existence of an AD subpopulation with a
surprising property of the increased intracerebral and
whole brain volumes. The experiments have been repeated
on a set of 659 ADNI patients described with 56 biological
and 187 clinical properties collected during the baseline
evaluation [14]. In spite of different datasets (though some
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of the patients and some of the features were overlapping),
again a cluster of male patients has been identified with the
same surprising property of increased intracerebral and
whole brain volumes. This work is an extension of these
experiments on the latter dataset but with an improved
clustering algorithm. The improvement resulted in identi-
fication of an additional cluster of male patients with no
dementia, construction of significantly larger clusters, and
elimination of obvious outliers that have been present in
previous subpopulations. The basic conclusions of this
work are the same as those in [14] but the statistical sig-
nificance of the results is higher.
3 Data
All experiments were performed on the data from the Alz-
heimer’s Disease Neuroimaging Initiative (ADNI) data-
base.1 The total number of patients initially included was
1736 from all ADNI stages of study (i.e., ADNI-1, ADNI-
GO, and ADNI-2). In order to achieve the broadest clinical
dataset, some exams used only in ADNI-2 were used.
Keeping only observations for which nomissing values were
present led to a reduction in the number of observations from
1736 to 659. This subset includes 317 female and 342 male
patients. The patients are described by 147 clinical variables,
41 laboratory variables, 40 symptoms, and 15 biological
measurements. Clinical variables include Alzheimer’s Dis-
ease Assessment Scale (ADAS13), Mini Mental State
Examination (MMSE), Rey Auditory Verbal Learning Test
(RAVLT immediate, learning, forgetting, percentage of
forgetting), Functional Assessment Questionnaire (FAQ),
Montreal Cognitive Assessment (MOCA), and Everyday
Cognition, which are cognitive functions questionnaire filled
out by patients (ECogPt) and their study partners (ECogSP)
(Memory, Language, Visuospatial Abilities, Planning,
Organization, Divided Attention, and the Total score),
Neuropsychiatric Inventory Questionnaire, Modified
Hachinski Ischemia Scale, and Geriatric Depression Scale.
Examples of laboratory variables are red blood cells and total
bilirubin, while examples of symptoms are palpitations and
dizziness. Biological measurements include ABETA pep-
tides, TAU and PTAU proteins, the APOE-related genetic
variations (APGEN1 genotype allele 1, APGEN2 genotype
allele 2), PET imaging results FDG-PET and AV45, MRI
volumetric data [Ventricles, Hippocampus, Whole Brain,
Entorhinal, Fusiform gyrus, Middle temporal gyrus (Mid-
Temp) and intracerebral volume (ICV)].
For the evaluation of the consistency of constructed
clusters, we use global clinical dementia rating score which
is interpreted as clinically normal CN (value 0), mild
cognitive impairment MCI (value 0.5) and Alzheimer’s
disease AD (value 1) diagnosis for the patient. The clinical
dementia rating score is different from the five level ADNI
patient diagnosis (cognitive normal, significant memory
concern, early mild cognitive impairment, late mild cog-
nitive impairment, and AD), but the agreement between the
two scales is very high.
In clustering, the symmetry and additivity of the variables
prove to be important. Therefore, in data preprocessing,
some of the variables were transformed to achieve reduced
skewness. The transformation function was selected
according to the type of data measured by the variable, the
level of skewness, and the most adequate function from a set
of possible functions, which include log x, logit x, 1/x, etc.
4 Multi-layer clustering
In a typical machine learning setting, we have a set of
examples E that are described by a set of attributes A, and
from these examples we try to induce or learn a model that
would generalize the examples. In some domains, the set of
attributes may be partitioned in two or more disjoint sub-
sets (layers) according to some criteria, such as the phys-
ical meaning of the attributes or the way data on specific
attributes have been collected. For example, in the Alz-
heimer’s disease domain, the first layer can be the labo-
ratory data, while the second layer can be the clinical data.
In some other domain, different layers may contain the
same attributes but collected in various time periods. The
goal of multi-layer clustering is to construct clusters that
are as large as possible and coherent in all the layers. This
section describes the proposed clustering methodology by
first describing single-layer clustering, and then general-
izing it to multi-layer clustering.
4.1 Single-layer clustering
Let us assume a basic clustering task in which we have
only one layer of attributes. The proposed methodology
consists of two steps. In the first step, we compute the so-
called example similarity table. This is an N 9 N sym-
metric matrix, where N is the number of examples. All its
values are in the range 0.0–1.0. A large value at a position
(i, j), i 6¼ j, denotes a large similarity between examples
i and j. In the second step, we use the table in order to
construct clusters.
1 The ADNI was launched in 2003 by the National Institute on Aging
(NIA), the National Institute of Biomedical Imaging and Bioengi-
neering (NIBIB), the Food and Drug Administration (FDA), private
pharmaceutical companies and non-profit organizations. The Princi-
pal Investigator of this initiative is Michael W. Weiner, MD, VA
Medical Center and University of California, San Francisco. More
information can be found at http://www.adni-info.org and http://adni.
loni.usc.edu.
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4.1.1 Example similarity table (EST)
We start from the original set of N examples described by
nominal and numerical attributes that may contain
unknown values. An artificial classification problem is
formulated as follows: the examples from the original set
constitute the positive examples, while the negative
examples are artificially constructed by shuffling the values
of the original examples. The shuffling is performed at the
level of attributes so that we randomly mix values among
the examples. The values remain within the same attribute
as in the original set of examples. As a result, we have the
same values in positive and negative examples, but in
negative examples we have randomized connections
between the attribute values. For small problems with up to
200 examples, we typically construct four times as many
negative examples as in the original (positive) example set,
while for larger domains we construct the same number of
positive and negative examples.
Next, we use a supervised machine learning algorithm to
build a predictive model that is used to discriminate
between the positive examples (the original examples) and
the negative examples (the artificially constructed exam-
ples with shuffled attribute values). The goal of learning is
not the predictive model itself, but the information on the
similarity of examples. Machine learning approaches with
which we can determine if some examples are classified in
the same way are appropriate for this task. For example, in
decision tree learning this means that examples end in the
same leaf node, while in decision rule learning this means
that examples are covered by the same rule.
To estimate the similarity of examples, we follow an
ensemble learning approach, where statistics are computed
over a large set of classifiers. Additionally, a necessary
condition for a good similarity estimation is that the clas-
sifiers are as diverse as possible and that each of the
classifiers is better than random. All these conditions are
satisfied, e.g., by the Random Forest [15, 16] and the
Random Rules [17] algorithms. We use the latter approach
in which we typically construct about 50,000 rules for each
EST computation.
The similarity of examples is determined so that for
each pair of examples, we count how many rules cover
both examples. The EST presents the statistics for the
positive examples (original set of examples). A pair of
similar examples will be covered by many rules, while no
rules or a very small number of rules will cover pairs that
are very different in terms of their attribute values. Final
EST values are computed by normalizing the counts by the
largest detected value.
Table 1 presents an example of EST for a set of 6
examples. In the upper part is the table with counts of rules
covering pairs of examples. The diagonal elements
represent total counts of rules covering each example. By
the normalization of this table, we obtain the EST that is
presented in the lower part of the table. It can be noticed
that we have two very similar examples (ex2 and ex5),
three similar examples (ex1, ex3, and ex4), and one very
different example (ex6). The maximal value in the upper
table is 97 and EST values in the lower table are obtained
through normalization with this value.
4.1.2 Clustering-related variability (CRV) score
The second step in the process of clustering starts from the
EST. The goal is to identify subsets of examples that can
reduce the variability of EST values. For this purpose, we
define the so-called clustering-related variability (CRV)
score. This is the basic measure which guides the search
during iterative bottom-up clustering. CRV score is not a
simple similarity measure. It is defined for a single
example, but it depends also on other examples that this
example is clustered with. A cluster may consist of a single
example.
Clustering-related variability, for example i is denoted
as CRVi. It is the sum of squared deviations of EST values
in row i (Xi ¼ fxi;j; j 2 f1; . . .; i 1; iþ 1; . . .;Ngg) but so
that CRVi is computed as a sum of two components:
CRVi ¼ CRVi;wc þ CRVi;oc.
Within cluster value
CRVi;wc ¼
X
j2C
ðxi;j  xmean;wcÞ2
is computed as a sum over columns j of row i (j 6¼ i)
corresponding to examples included in the same cluster
C with example i. In this expression, xmean;wc is the mean
value of all xi;j in the cluster. When there is only one
Table 1 An illustrative example of a similarity table (EST)
ex1 ex2 ex3 ex4 ex5 ex6
ex1 38 0 27 28 0 7
ex2 0 97 3 1 97 3
ex3 27 3 47 16 3 1
ex4 28 1 16 45 1 4
ex5 0 97 3 1 97 3
ex6 7 3 1 4 3 39
ex1 ex2 ex3 ex4 ex5 ex6
ex1 0.39 0.0 0.28 0.29 0.0 0.07
ex2 0.0 1.0 0.03 0.01 1.0 0.03
ex3 0.28 0.03 0.48 0.16 0.03 0.01
ex4 0.29 0.01 0.16 0.46 0.01 0.04
ex5 0.0 1.0 0.03 0.01 1.0 0.03
ex6 0.07 0.03 0.01 0.04 0.03 0.40
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example in a cluster then CRVi;wc ¼ 0 because there are no
other examples in the cluster that are different from
i. When there are two examples in a cluster then it equals
zero because we compute the sum only for one value xi;j
and that is equal to xmean;wc ¼ xi;j.
Outside cluster value
CRVi;oc ¼
X
j 62C
ðxi;j  xmean;ocÞ2
is defined in the same way as CRVi;wc but for xi;j values of
row i not included in cluster C. The xmean;oc is the mean
value of the EST element values not included in the cluster
and it is different from the xmean;wc used to compute
CRVi;wc. When example i is the only example in a cluster
then CRVi;oc is the sum of squared deviations for all the
values in row i except for xi;i.
The final CRV value of cluster C is computed as the sum
of all the CRV values for the examples contained in the
cluster:
CRVC ¼
X
i2C
CRVi:
4.1.3 Illustrative example
We use the data from the EST presented in Table 1 to
compute the CRV value for the example (ex1) contained in
various clusters C. We present three cases: when cluster
C contains only example ex1, when ex1 is clustered with
ex3, and, finally, when it is clustered with both ex3 and ex4.
By visual inspection of the EST, we can immediately
notice some similarity among examples fex1; ex3; ex4g.
The goal is to demonstrate the CRV value computation to
show that for the same row ex1, we can get different
CRVex1 values depending on which example ex1 is clus-
tered with, and finally to show how CRVex1 values decrease
when similar examples are added into cluster C.
If ex1 is the only example in a cluster C ¼ fex1g:
CRVex1;wc ¼ 0
CRVex1;oc ¼ ð0:0 0:13Þ2 þ ð0:28 0:13Þ2þ
ð0:29 0:13Þ2 þ ð0:0 0:13Þ2 þ ð0:07 0:13Þ2 ¼ 0:08
CRVex1 ¼ 0:08
When we add a new element (ex3) to this cluster
C ¼ fex1; ex3g:
CRVex1;wc ¼ ð0:28 0:28Þ2 ¼ 0:00
CRVex1;oc ¼ ð0:0 0:09Þ2 þ ð0:29 0:09Þ2þ
ð0:0 0:09Þ2 þ ð0:07 0:09Þ2 ¼ 0:06
CRVex1 ¼ 0:06
Finally, when we have C ¼ fex1; ex3; ex4g:
CRVex1;wc ¼ ð0:28 0:285Þ2 þ ð0:29 0:285Þ2 ¼ 0:00
CRVex1;oc ¼ ð0:0 0:02Þ2 þ ð0:0 0:02Þ2þ
ð0:07 0:02Þ2 ¼ 0:00
CRVex1 ¼ 0:00
4.1.4 Single-layer algorithm
Algorithm 1 is the bottom-up clustering algorithm that
merges the most similar examples in respect of the CRV
score, and produces a hierarchy of clusters. It may be
noticed that in contrast to most other clustering algorithms,
it has a well-defined stopping criterion. The process stops
when further merging does not result in the reduction of
example variability measured by the CRV score, and this
way the algorithm automatically determines the optimal
number of clusters. As a consequence, some examples may
stay non-clustered (more precisely, they remain as clusters
consisting of only one example).
x y
CRVx CRVi x
CRVy CRVi y
CRVxy CRVi x y
DIFF = CRVx+CRVy − CRVxy
x y
x y
4.2 Multi-layer clustering
The basic lesson learned from redescription mining and
multi-view clustering is that the reliability of clustering can
be significantly improved by a requirement that the result
should be confirmed in two or more attribute layers. The
approach for clustering based on example similarity, pre-
sented in the previous section for a single-layer case, can
be easily extended to clustering in a multi-layer case.
If we have more than one attribute layer then for each of
them we compute the example similarity table indepen-
dently. For each layer, we have to construct its own arti-
ficial classification problem and execute the supervised
learning process in order to determine the similarity of
examples. Regardless of the number and type of attributes
in different layers, the tables will be always matrices of
dimension N 9 N. The reason is that by definition, we
have the same set of N examples in all the layers. After
computing the similarity tables, the second step of the
clustering process is executed.
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x y
l
CRVlx CRV x l
CRVly CRV y l
CRVlxy CRV {x ∪ y} l
DIFFl = CRVlx+CRVly − CRVlxy
x y DIFF = minlDIFFl
x y
x y
Conceptually, multi-layer clustering presented in Algo-
rithm 2 is identical to the single-layer approach. The main
difference is that merging of two clusters is possible only if
there is variability reduction in all the layers. For each
possible pair of clusters, we have to compute potential
variability reduction for all attribute layers and to select the
smallest value for this pair. If this minimal value is posi-
tive, then merging of clusters enables variability reduction
in all the layers. When there are more pairs with positive
minimal value, we chose the pair with the largest minimal
value and merge these clusters in the current iteration.
When we do clustering in two or more layers, we have a
conjunction of necessary conditions for merging two
clusters. A typical consequence is that resulting clusters are
smaller than in the case of a single-layer clustering.
5 Clustering results
Clustering was performed independently for each of the
two subpopulations of 317 female and 342 male patients. A
series of experiments was performed so that different parts
of available information about patients were used as input
layers. The presented results were obtained by using bio-
logical measurements and laboratory data (in total 56
descriptors) as the first layer, and symptoms and clinical
data (in total 187 descriptors) as the second layer.
All experiments produced a large number of clusters.
For the described setting with two layers for the female
population, there are 19 clusters with 4 or more patients,
nine of which have more than 10 patients. The result for the
male population is very similar: 21 clusters with 4 or more
patients, 10 of them with more than 10 patients. Five lar-
gest clusters for each population are listed in Table 2. They
include a bit more than a half of patients from each
population.
Table 3 presents the clinical and biological properties
for six clusters that include more than 30 patients. For the
female population, we have one large cluster F1 in which
the majority of patients have significant problems with
dementia. Out of the 47 included patients, 19 have the
Clinical Dementia rating score equal to 1 (in this work
interpreted as AD), while 28 have been diagnosed as mild
cognitive impairment (CD score of 0.5). In the entire
dataset, there are 22 patients with the score value equal to
1, and 19 of them are included into this cluster. The clinical
properties of these patients include high ADAS13, FAQ,
and MMSE scores, and all types of cognitive problems.
The biological properties of these patients are also typical
for AD patients, e.g., low FDG values, significantly
decreased Entorhinal volume, and high AV45 values. A
statistical comparison with the population of all 145 female
patients with cognitive normal status in the dataset has
been used to identify the most distinguishing biological
properties of the cluster. The last column of Table 3 pre-
sents the most significant properties in terms of the highest
z-score values of the Mann-Whitney test. The values are
very high denoting that differences between cognitive
normal patients and those included in the cluster are very
significant.2
Cluster F0 constructed for the female population
includes 64 patients that are typical patients with no sig-
nificant problems with dementia. Although this is the lar-
gest cluster constructed for the female population, it is
relatively small if we take into account that there are 145
Table 2 List of five largest clusters for female and male populations
Number of patients Distribution of CD rating score Cluster ID
AD MCI CN
Females
64 0 5 59 F0
47 19 27 1 F1
22 0 20 2 –
20 0 0 20 –
19 3 15 1 –
Males
42 0 12 30 M0A
40 0 8 32 M0B
38 18 20 0 M1
31 13 18 0 M2
27 0 26 1 –
2 A value of a z score higher than 3.29 denotes statistical significance
of P\ 0.001.
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cognitive normal female patients in the whole dataset. A
possible explanation is that among ADNI patients diag-
nosed as cognitive normal there are also patients that are
not completely healthy, but their subjective or objective
problems are either not severe enough or their problems are
in discrepancy with typical clinical profiles.
The bottom part of Table 3 presents clusters for the male
population. There are two clusters of patients with signif-
icant cognitive problems (M1 and M2) and two clusters of
patients with mild or no dementia (M0A and M0B). Cluster
M0A is similar in terms of the properties of the female
cluster F0 both regarding its size and the detected biolog-
ical properties. It is interesting to notice that cluster M0A
includes even 12 patients that have CD rating score equal
to 0.5 while in the female cluster there are only five such
patients. In contrast to cluster M0A, cluster M0B is char-
acterized by decreased ICV values.
There are two clusters of male patients that have sig-
nificant problems with dementia. In the first one (M1) there
are 38 patients, 18 of them with the CD score equal to 1
and the rest with the score equal to 0.5. In the second
cluster (M2) there are 31 patients, 13 of them with CD
score equal to 1. In the male population, there are a total of
36 patients with AD status (CD value equal to 1). An
interesting observation is that two male clusters M1 and
M2 together include 31 out of 36 (86 %) male patients with
CD score equal to 1 in the dataset, while the single female
cluster F1 includes almost identical percentage of such
patients (19 out of 22, i.e., 86 %). Table 4 lists the ADNI
IDs of patients included into clusters F0, F1, M0A, M0B,
M1, and M2.
6 Analysis of results
A significant difference between male and female popula-
tions of patients can be noticed. For the female population
there are two clusters while for the male population there
are four clusters, two for patients with significant problems
with dementia and two for patients with mild or no
dementia. By inspecting the properties characterizing
patients in these clusters (see Table 3), one can notice
especially interesting differences between patients in
clusters M1 and M2. Biological and clinical properties that
most significantly differentiate these two clusters according
to the Mann-Whitney test are listed in Table 5.
Cluster M2 deserves special attention due to the fact that
average values of ICV and whole brain volume for patients
in M2 are higher than average values for the set of all 124
cognitive normal male patients. The result is unexpected
because cognitive problems are typically related with the
atrophy of human brain [18]. The differences are statisti-
cally significant; average ICV values are 1,577 and 1,774
for cognitive normal and M2 patients, respectively ( z score
6.54, P\0.001) (see Table 3), while average whole brain
volumes are 1109 and 1167 ( z score 3.08, P\ 0.01).3
When comparing patients in cluster M2 with patients in
M1, who also have typical AD symptoms but, as expected,
decreased ICV and whole brain volumes, the differences
are even more statistically significant (see Table 5).
Table 3 Short descriptions for the largest clusters
Cluster
ID
Clinical status Biological properties
(with z score versus
cognitive normal)
Clusters for female patients
F1 Significant cognitive problems
(high ADAS13, high FAQ, high
MMSE)
Low FDG 9.29
Low entorhinal 8.74
High AV45 8.36
Low
hippocampus
8.33
Low MidTemp 7.52
Low fusiform 7.13
High TAU 7.12
F0 Mild or no dementia High FDG 6.05
High
hippocampus
2.86
High whole
brain
2.85
Clusters for male patients
M1 Significant cognitive problems Low FDG 8.23
Low
hippocampus
7.70
Low entorhinal 7.09
Low MidTemp 6.33
Low whole
brain
6.23
High TAU 5.57
M2 Significant cognitive problems Low FDG 7.83
High ICV 6.54
High ventricles 5.70
Low
hippocampus
5.60
Low ABETA 5.80
M0A Mild or no dementia High FDG 4.98
High ICV 4.00
High whole
brain
3.31
M0B Mild or no dementia Low ICV 4.83
Low whole
brain
3.74
3 Actual absolute values for ICV and whole brain volumes are 1000
times larger.
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The importance of the discovery is manifold. First, it
indicates gender-specific differences because such a cluster
with similar properties is not detected in the female pop-
ulation. Second, for a domain in which biological processes
with opposite manifestations (decrease and increase of
ICV) may result in similar clinical consequences (demen-
tia), segmentation of the patient population is suggested
before other analyses aimed at the discovery of relations
between biological and clinical properties of patients are
performed. Finally, the result is intriguing in respect of its
biological and medical interpretation.
It is possible that the increased ICV and whole brain
volumes are a consequence of an artifact in data collection
procedures, feature extraction from images, or data post-
processing (normalization). The assumption may stimulate
careful evaluation of the ADNI data, especially for patients
in cluster M2. But the result may also suggest the existence
of a different biological pathway for the male population,
resulting in serious dementia problems that are often
diagnosed as Alzheimer’s disease but with less expressed
clinical symptoms (see bottom part of Table 5). In the
scientific literature, we have found no support for such
explanation except that the study devoted to gender-related
differences [2] concluded that ‘‘AD pathology is more
likely to be clinically expressed as dementia in women than
in men.’’
Figure 1 illustrates the differences among patients in
clusters M1 and M2 and cognitive normal male patients
in respect of ICV values and ADAS13 scores. It can be
noticed that male cluster M0A can be compared with
female cluster F0 because they share common properties:
increased ICV and decreased ADAS13 score when
compared to mean values of all cognitive normal male
and female patients, respectively. Cluster M0B is again a
surprise because it represents a group of patients which
also has improved (lower) ADAS13 values but with
decreased values of ICV. The differences between
cluster M0B and the complete cognitive normal male
patients are not statistically significant but the result
additionally stresses differences between male and
female populations and suggests that the differences
between clusters M1 and M2 that are valid for AD
patients are to some extent present also in the cognitive
normal population.
Table 4 Lists of ADNI patients
included into clusters from
Table 3
For clusters F1, M1, and M2,
RIDs of patients with the
diagnosis of the Alzheimer’s
disease (CDGLOBAL value
equal to 1) are typeset in bold,
while for clusters F0, M0A, and
M0B, patients with the MCI
diagnosis (CDGLOBAL value
equal to 0.5) are typeset in bold
Cluster F1
4024 4030 4034 4058 4079 4201 4209 4211 4252 4324 4353 4402 4415 4458
4477 4500 4502 4542 4568 4591 4609 4660 4715 4796 4815 4845 4894 4897
4902 4904 4905 4906 4909 4910 4912 4918 4982 4984 4990 4997 5006 5015
5019 5031 5063 5119 5184
Cluster M1
4009 4095 4096 4131 4152 4171 4195 4215 4240 4307 4475 4494 4501 4526
4625 4672 4686 4689 4707 4718 4770 4774 4802 4827 4857 4867 4936 4958
4964 4968 4980 4994 5017 5027 5067 5165 5224 5241
Cluster M2
4136 4153 4192 4223 4243 4258 4346 4423 4515 4546 4549 4595 4615 4661
4692 4733 4859 4863 4924 4943 4971 4974 5012 5037 5058 5059 5070 5071
5095 5208 5210
Cluster F0
4028 4066 4076 4084 4155 4184 4200 4288 4320 4335 4340 4349 4357 4362
4399 4401 4422 4441 4446 4483 4496 4508 4545 4553 4555 4598 4607 4624
4643 4644 4645 4843 4872 4874 4878 4900 4952 5093 5102 5118 5127 5129
5132 5154 5158 5159 5169 5175 5185 5193 5198 5203 5214 5230 5235 5240
5261 5272 5277 5287 5288 5289 5290 5292
Cluster M0A
4029 4037 4043 4082 4164 4177 4179 4210 4225 4229 4257 4274 4309 4332
4339 4345 4352 4389 4427 4429 4431 4453 4485 4516 4520 4556 4604 4632
4649 4739 4844 4921 4926 4941 4966 5113 5131 5141 5157 5242 5271 5296
Cluster M0B
4086 4090 4103 4158 4168 4176 4251 4292 4369 4391 4400 4443 4464 4469
4491 4577 4579 4601 4620 4762 4799 4813 4862 4877 5082 5083 5109 5130
5135 5147 5150 5167 5212 5243 5248 5250 5266 5278 5279 5294
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7 Biological markers
One of the stated ADNI goals is to improve clinical trial
design through detection of biomarkers that could be used
as approximate measures of the severity of dementia. This
is known as a difficult task that is still far from a satis-
factory solution. If the constructed clusters are really more
homogeneous than the complete population, then it may be
expected that identification of dementia disease markers
should be an easier task for each cluster separately than it is
for the complete population.
Table 6 presents the most correlated pairs of one bio-
logical and one clinical property that can be identified for
the complete population, for the female population only,
for the male population only, and finally for clusters F1,
M1, and M2. The most correlated pairs are identified with
the Spearman rank-order correlation coefficient rs that is
computed for all possible pairs of properties. The result
confirms that for some constructed clusters there exist more
strongly correlated biological–clinical relations.4 It must be
noted that in spite of a high correlation coefficient value,
the statistical significance of correlation for the smallest
cluster is smaller than for the larger clusters because of its
size. The result means that detected high correlation is not
so reliable and that it has to be confirmed by further
experiments. As expected, FDG is the most useful bio-
logical property for the general patient population and the
result is in agreement with previously reported research [7].
8 Conclusions
The presented results confirm that novel machine learning
approaches to clustering can indeed be a useful tool for
identifying homogeneous patient subsets in various medi-
cal knowledge discovery tasks. The applied multi-layer
clustering technique and its combination with the gender-
related separation of the population of patients is definitely
not the only possible approach but its results are promising.
Still, significant further research effort in this direction is
necessary. Clusters constructed with the multi-layer clus-
tering are small and six largest clusters together contain
only about 40 % of all patients. In spite of this, the analysis
of the results supports the conclusion that there are
Table 5 Biological and clinical properties that are most significantly different for patients in clusters M1 and M2
Property Average value for
cognitive normal males
Average value
for M2
Average value
for M1
Mann-Whitney z score
M1 versus M2
Biological properties
ICV (*1000) 1577 1774 1479 6.98
Whole brain (*1000) 1109 1167 983 6.12
MidTemp 21629 20127 17930 3.84
Hippocampus 7808 6530 5722 3.47
Fusiform 19593 18457 16672 3.37
Ventricles 35686 64375 47414 2.47
Clinical properties
Abstraction_moca 1.81 1.64 1.14 2.85
Neuropsychiatric Inv.
(impatience)
0.29 0.52 1.78 2.07
Naming_moca 2.92 2.82 2.38 1.78
FAQTV 0.10 1.97 2.62 1.62
Fig. 1 Average values of Alzheimer’s Disease Assessment Scale
(ADAS13) and intracerebral volume (ICV) for all females with
clinical dementia rating score equal zero (black circle), females in
cluster F0 (black triangle), females in cluster F1 (black square), all
males with clinical dementia rating score equal zero (white circle),
males in clusters M0A and M0B (white triangles), and males in
clusters M1 and M2 (white squares)
4 Only the absolute value is important, the negative sign means an
inverse correlation.
Clusters of male and female Alzheimer’s disease patients 177
123
significant gender-specific differences in Alzheimer’s dis-
ease. Additionally, for the male population, two subpopu-
lations with surprising properties have been detected: A
subpopulation of AD patients with increased ICV and
whole brain volumes and a subpopulation of cognitive
normal patients with decreased ICV volume. The result
suggests that segmentation of the AD patient population is
strongly recommended as a preprocessing step for any
analysis aimed at understanding of relations between bio-
logical and clinical properties of AD patients; however,
based on the available data, we still do not know how to
practically perform the segmentation in a non ad-hoc
manner for the majority of patients with cognitive
problems.
In future work, we plan to compare multi-layer clus-
tering with redescription mining and to test if results of
redescription mining might be used for human under-
standable interpretation of clusters obtained by the multi-
layer approach. Regarding medical evaluation, we plan to
test if it is possible to identify M1 and M2 clusters on non-
ADNI patients. The ultimate goal would be to better
understand differences between these two populations.
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